# NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
> **NDA215700** · New Drug Application · Sponsor: INFORLIFE · Approved 2022-09-15
## Drug
- **FDA Application Number:** NDA215700
- **Application type:** New Drug Application
- **Brand name:** NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
- **Generic name:** NOREPINEPHRINE BITARTRATE
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** INFORLIFE
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 2022-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215700)
---
*MORVS · CC0 1.0*